Hematology ·
Virtual Reality Feasibility Pilot Reports Lower Pain Scores During Sickle Cell Episodes
In a prospective pre-post pilot study of 20 adults with sickle cell disease, pain scores fell after participants used a virtual reality headset during vaso-occlusive episodes. Most participants reported some distraction from pain, but the uncontrolled study cannot establish whether VR caused the change.
- Study included 20 adults with sickle cell disease.
- Mean pain scores fell from 7.25 to 6.35 after VR.
- Three-quarters reported at least some distraction from pain.
- Uncontrolled pilot results need confirmation in larger studies.
A prospective pilot pre-post study assessed virtual reality (VR) as an adjunctive, non-pharmacologic intervention during vaso-occlusive episodes in 20 adults with sickle cell disease. Participants used a VR application with a Meta Quest 3 headset. Pain was rated on a 0–10 scale immediately before and after use; feasibility and acceptability were assessed through reports of pain distraction and simulation sickness symptoms.
Mean pain scores decreased from 7.25 before VR to 6.35 afterward (p=0.002). Seventy-five percent of participants said VR helped distract them from pain at least somewhat, and 85% experienced mild or no simulation sickness symptoms.
The findings suggest VR was feasible and acceptable in this small sample, but the pre-post design without a control group cannot determine whether VR produced the pain reduction. The authors call for larger controlled studies; these results do not establish VR as an effective substitute for established VOE pain management.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Journal of General Internal Medicine: Feasibility and Acceptability of Virtual Reality for Pain Relief During Vaso-occlusive Episodes in Sickle Cell Disease: A Pilot Study ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.